Investing in Africa Healthcare: Delivering Financial and Impact Returns
Healthcare is a popular investment theme for institutional investors and private equity groups, attracted by expanding populations spending more out of their own pockets on private medical services in countries where state provision is inadequate or underfunded. Emmanuel Katongole, MD and CEO of Cipla Quality Chemical Industries Limited (CQCIL) adopts a pragmatic approach to detail the success of CQCIL in delivering returns, impact and local expertise. CQCIL is the only company in Sub-Saharan Africa, that is authorized to manufacture triple-combination anti retroviral drugs.
EMMANUEL KATONGOLE, MD/CEO OF CIPLA QUALITY CHEMICAL INDUSTRIES LTD